Orient EuroPharma Co., Ltd. (TPEX:4120)
Taiwan · Delayed Price · Currency is TWD 46.90
-0.10 (-0.21%)
Jul 29, 2026, 1:30 PM CST
Orient EuroPharma Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 4,590 | 4,595 | 4,391 | 4,592 | 4,730 | 4,767 |
Revenue Growth | 3.30% | 4.64% | -4.37% | -2.93% | -0.77% | -11.45% |
Gross Profit Gross Profit Growth | 2,279 | 2,237 | 2,066 | 2,147 | 2,032 | 2,151 |
Operating Income Operating Income Growth | -217.62 | -310.54 | -6.72 | 70.61 | -149.54 | -95.68 |
Net Income Net Income Growth | -438.65 | -567.39 | -283.93 | 143.94 | -310.8 | 120.17 |
Earnings Per Share EPS Growth | -5.06 | -6.54 | -3.27 | 1.66 | -3.58 | 1.38 |
EPS Growth | - | - | - | - | - | -39.74% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Western Medicine Section Western Medicine Section Growth | 2,904 | 2,909 | 2,744 | 2,426 | 2,327 | 2,230 |
Nutrition and Health Sector Nutrition and Health Sector Growth | 1,686 | 1,686 | 1,647 | 2,166 | 2,403 | 2,537 |
Total Total Growth | 4,590 | 4,595 | 4,391 | 4,592 | 4,730 | 4,767 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,854 | 2,086 | 1,609 | 1,896 | 1,872 | 2,040 |
Total Debt Total Debt Growth | 3,355 | 3,260 | 4,229 | 4,841 | 5,024 | 4,221 |
Net Cash (Debt) Net Cash Growth | -1,502 | -1,175 | -2,620 | -2,946 | -3,153 | -2,181 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -17.31 | -13.54 | -30.20 | -33.88 | -36.34 | -25.08 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -264.12 | -292.21 | -121.11 | 64.67 | -218.75 | 77.65 |
Capital Expenditures CapEx Growth | -244.54 | -173.67 | -99.06 | -99.4 | -639.16 | -1,563 |
Free Cash Flow Free Cash Flow Growth | -508.66 | -465.88 | -220.16 | -34.73 | -857.91 | -1,485 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 49.65% | 48.69% | 47.05% | 46.76% | 42.96% | 45.12% |
Operating Margin | -4.74% | -6.76% | -0.15% | 1.54% | -3.16% | -2.01% |
Pretax Margin | -3.20% | -5.94% | -2.96% | 5.58% | -6.94% | 1.78% |
Profit Margin | -9.56% | -12.35% | -6.47% | 3.14% | -6.57% | 2.52% |
FCF Margin | -11.08% | -10.14% | -5.01% | -0.76% | -18.14% | -31.16% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 4.000 | 4.000 | 1.000 | 1.000 | - | 0.850 |
Dividend Per Share Growth | 300.00% | 300.00% | 0% | - | - | -43.33% |
Dividend Yield | 8.51% | 9.74% | 2.30% | 2.91% | - | 2.72% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | 23.44 | - | 26.24 |
Forward PE | - | 17.63 | 17.63 | 17.63 | 17.63 | 17.63 |
PS Ratio | 0.89 | 0.85 | 0.95 | 0.74 | 0.66 | 0.66 |